Coupons, Vouchers Are Dilemmas For Industry Under Vermont Drug Sample Reporting Law
As pharma companies begin to implement a Vermont law requiring them to report who receives their drug samples, they remain uncertain about some of the details.
You may also be interested in...
Pharmaceutical companies will have a little more than a year to put together data to comply with CMS regulations for reporting payments made to physicians if the agency meets its current timeline for issuing the rules.
Our infographic illustrates the recommendations in FDA’s COVID-19 pandemic recovery and preparedness plan, ranging from strengthening the EUA process to managing the backlog of pending inspections.